Retrospective evaluation of borderline ovarian tumors: single center experience of 183 cases

Basit Öğe Kaydı
dc.contributor.authorGüngör, Tayfun
dc.contributor.authorÇetinkaya, Nilufer
dc.contributor.authorYalçın, Hakan
dc.contributor.authorÖzdal, Bülent
dc.contributor.authorÖzgü, Emre
dc.contributor.authorBaşer, Eralp
dc.contributor.authorErkaya, Salim
dc.date.accessioned2020-04-30T23:31:42Z
dc.date.available2020-04-30T23:31:42Z
dc.date.issued2015
dc.departmentDÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.descriptionOzgu, Emre/0000-0002-8444-9694; Gungor, Tayfun/0000-0002-7869-9662; Uygur, Dilek/0000-0001-8567-9048en_US
dc.descriptionWOS: 000347289600020en_US
dc.descriptionPubMed: 25047273en_US
dc.description.abstractBorderline ovarian tumors (BOTs) constitute about a quarter of epithelial ovarian malignancies and require different treatment approaches. The present study aims to document the experience of a single center on the treatment outcome of women who had conservative or comprehensive surgery for BOTs. One hundred eighty-three patients with BOTs, diagnosed and/or treated in our center between January of 2000 and March of 2013, were reviewed retrospectively. The mean age at diagnosis was 40.6 years old (range 17-78). Ninety-five patients (51 %) were a parts per thousand currency sign40 years. Comprehensive surgical staging and fertility sparing surgery were performed in 49 % (n = 91) and 48 % of patients (n = 89) respectively. A hundred and forty-seven patients had stage IA disease (80 %). The most common type of BOT was serous in histology with 18 % bilateralism. CA-125 and CA-199 levels were increased in 29 (19 %) and 15 (10 %) patients with stage IA disease. Non-invasive tumor implants were diagnosed in 9 patients (4 %) and uterine involvement was 2 % among BOT patients that underwent hysterectomies. The mean post-operative follow-up period was 20.4 months (range 6-78 months). Disease recurrence was seen in 5 patients indicating overall recurrence rate of 2.7 %. In our study, we evaluated a large data pool of 183 patients diagnosed with borderline epithelial ovarian tumors. BOTs have a relatively better prognosis than invasive epithelial ovarian cancer. Surgery with proper staging is the cornerstone of treatment. Patients with BOTs at the early stage can undergo fertility sparing surgery with close follow-up.en_US
dc.identifier.doi10.1007/s00404-014-3381-7en_US
dc.identifier.endpage130en_US
dc.identifier.issn0932-0067
dc.identifier.issn1432-0711
dc.identifier.issue1en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage123en_US
dc.identifier.urihttps://doi.org/10.1007/s00404-014-3381-7
dc.identifier.urihttps://hdl.handle.net/20.500.12684/4417
dc.identifier.volume291en_US
dc.identifier.wosWOS:000347289600020en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofArchives Of Gynecology And Obstetricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOvarian canceren_US
dc.subjectBorderline ovarian tumorsen_US
dc.subjectFertility sparing surgeryen_US
dc.titleRetrospective evaluation of borderline ovarian tumors: single center experience of 183 casesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
4417.pdf
Boyut:
214.11 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu